ArticleApplied biochemistry and biotechnology2025
Galactose Oxidase and Horseradish Peroxidase Hybrid Nanoflowers for Biosynthesis of 1-Tetralone.
Article in Applied biochemistry and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Organic-inorganic hybrid nanoflowers as novel enzyme immobilization scaffolds have garnered increasing attention due to their high specific surface area and facile preparation conditions. Here, multiple enzyme hybrid nanoflower (GO&HRP-hNF) was obtained by using galactose oxidase (GO) and horseradish peroxidase (HRP) as the inner protein components and copper phosphates as the inorganic agents, which catalyzed the oxidation of 1-tetralol into 1-tetralone. The yield of 1-tetralone obtained from GO&HRP-hNF (49.96 ± 2.8%) was 1.4 times higher than that of the free enzyme system (35.75 ± 1.8%). GO&HRP-hNF displayed comparable kinetic parameters with free GO and remarkably enhanced stability under high temperature. Moreover, GO&HRP-hNF retained 80% of its initial activity even after 30 repeated catalytic cycles, demonstrating its satisfactory reusability. This study provides an avenue for the synthesis of 1-tetralone from 1-tetralol by using immobilized multi-enzyme composites in industrial applications.
Indexed as
Identifiers
40627110What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.